metadon "dne" 5 mg/ml oral opløsning
dne pharma as - methadonhydrochlorid - oral opløsning - 5 mg/ml
methadon "alternova" 20 mg tabletter
alternova a/s - methadonhydrochlorid - tabletter - 20 mg
methadon "alternova" 5 mg tabletter
alternova a/s - methadonhydrochlorid - tabletter - 5 mg
methadon "martindale pharma" 2 mg/ml oral opløsning
ethypharm - methadonhydrochlorid - oral opløsning - 2 mg/ml
marlodon 10 mg tabletter
eql pharma ab - methadonhydrochlorid - tabletter - 10 mg
marlodon 20 mg tabletter
eql pharma ab - methadonhydrochlorid - tabletter - 20 mg
marlodon 40 mg tabletter
eql pharma ab - methadonhydrochlorid - tabletter - 40 mg
dutrebis
merck sharp dohme limited - lamivudin, raltegravir kalium - hiv infektioner - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - dutrebis angives i kombination med andre anti‑retroviral lægemidler til behandling af human immundefekt virus (hiv‑1) infektion hos voksne, unge og børn i alderen fra 6 år og vejer mindst 30 kg uden nuværende eller tidligere bevis for viral modstandsdygtigheden over for antivirale stoffer af insti (integrase strand overføre hæmmer) og nrti (nucleoside reverse transkriptase hæmmer) klasser (se afsnit 4. 2, 4. 4 og 5.
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacinhydrochlorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv skal bruges som en del af et omfattende adhd behandling program, typisk, herunder psykologiske, pædagogiske og sociale foranstaltninger.
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberkulose, multidrugt-resistent - antimyco-bakterielle midler - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..